| JNP Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the JNP market cap history going back to 8/9/2013:
Also see: JNP Shares Outstanding History and JNP YTD Return |
JNP Market Cap History — Juniper Pharmaceuticals Capitalization Over Time
As of 8/3/2018 Juniper Pharmaceuticals has a market cap of 129.61 million. Investors often follow the JNP market cap history to compare the size of the company over time.
This page shows JNP market capitalization trends over time, with 22 market cap datapoints presented, dating back to 8/9/2013.
| JNP Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
JNP Historical Market Cap: +15.29% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| JNP Stock Price Chart |
| About Juniper Pharmaceuticals Inc |
| Juniper Pharmaceuticals is healthcare company with core businesses consisting of its Crinone® (progesterone gel) franchise. Co. has two segments: product, which oversees the supply chain and manufacturing of Crinone®, an 8.0% progesterone bioadhesive vaginal gel designed for progesterone supplementation or replacement as part of an assisted reproductive technology treatment for infertile women with progesterone deficiency; and service, which includes pharmaceutical development, clinical trial manufacturing, and analytical and consulting services for Co.'s customers, as well as characterizing and developing pharmaceutical product candidates for Co.'s internal programs. We show 22 historical shares outstanding datapoints in our JNP shares outstanding history coverage, used to compute JNP market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing JNP market cap history over the course of time is important for investors interested in comparing JNP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of JNP versus a peer is one thing; comparing JNP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like JNP can fluctuate over the course of history. With this page we aim to empower investors researching JNP by allowing them to research the JNP market cap history. |
| JNP Current Stock Quote |
Quotes delayed 20 minutes  Free JNP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| JNP Share Performance |
| Market Cap Peers |
| Juniper Pharmaceuticals (JNP) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
JSPR Market Cap History JUNS Market Cap History KA Market Cap History KALA Market Cap History KALV Market Cap History KDMN Market Cap History KDNY Market Cap History KEQU Market Cap History KERX Market Cap History KIDS Market Cap History More Healthcare companies » |
JNP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
